Aripiprazole Bioequivalence Query [Regulatives / Guidelines]

posted by shankar – India, 2013-12-16 06:35 (4579 d 00:27 ago) – Posting: # 12060
Views: 5,142

Dear Helmut,

Please let me know why FDA guidance for Aripiprazole bioequivalence study recommending Fasting and fed study for 10 mg and fasting study for 5 mg?

The strength available is 2 mg, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg and the literature indicates Aripiprazole having liner pharmacokinetics.

If the drug has linear kinetics why BE study conducted for 5 mg also?

Regards,

Shankar


Edit: Moved to a previous post. [Helmut]

Shankaranarayanan

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
313 visitors (0 registered, 313 guests [including 22 identified bots]).
Forum time: 08:03 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5